Today: 12 March 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Air China cashes out $170 million Cathay Pacific stake as a Qatar buyback reshapes the shareholder map

Air China cashes out $170 million Cathay Pacific stake as a Qatar buyback reshapes the shareholder map

Air China is selling 108.1 million shares in Cathay Pacific for HK$1.32 billion ($170 million), cutting its stake to just under 30% after a planned buyback. Swire Pacific’s holding will rise to about 47.65%. The sale price is HK$12.22 per share, with completion expected by Jan. 8. Filings show the deal depends on takeover-rule waivers and regulatory approvals.
8 January 2026
Dow Futures Slip After Jobless Claims; Trump’s $1.5 Trillion Pentagon Talk Lifts Defense Stocks

Dow Futures Slip After Jobless Claims; Trump’s $1.5 Trillion Pentagon Talk Lifts Defense Stocks

U.S. stock index futures slipped before Thursday’s open, with the Dow, Nasdaq 100, and S&P 500 down up to 0.4% in premarket trading. Defense shares surged after Donald Trump proposed a $1.5 trillion 2027 military budget. Apple and Tesla fell, while Alphabet rose nearly 1% after overtaking Apple in market value. Weekly jobless claims increased by 8,000 to 208,000.
Ondas stock slips after SEC filing tees up more shares for resale in Sentry deal

Ondas stock slips after SEC filing tees up more shares for resale in Sentry deal

Ondas Holdings shares fell about 5% to $12.18 in early trading Thursday after the company filed to register 1.67 million shares for resale tied to its Sentry CS acquisition. The shares were issued as part of a $2.5 million cash-and-stock payment on Jan. 8. Ondas will not receive proceeds from the resale. Investors are watching for updates at a Needham conference Jan. 14 and an investor day Jan. 16.
8 January 2026
Omeros stock rises in premarket after $36,000-a-vial Yartemlea price is set

Omeros stock rises in premarket after $36,000-a-vial Yartemlea price is set

Omeros Corp shares rose about 4% to $14.09 premarket after setting a $36,000 price for each vial of newly approved Yartemlea, used to treat TA-TMA in transplant patients. The company began its U.S. launch Jan. 2 and reported $171.5 million in cash at year-end. Shares jumped 6.6% in after-hours trading Wednesday. Analysts raised price targets following the announcement.
Intel stock jumps in premarket as 18A ramp talk keeps the turnaround trade hot

Intel stock jumps in premarket as 18A ramp talk keeps the turnaround trade hot

Intel shares jumped 6.4% to $42.63 in premarket trading Thursday after executives at CES said the company met its 18A chip production target for 2025 and began ramping Core Ultra Series 3. The company showed new “AI PC” laptops from 15 makers, with pre-orders starting this week. AMD and TSMC U.S. shares fell about 2% premarket, while Nvidia gained 1%. Intel will report Q4 and full-year results on Jan. 22.
American Airlines stock (AAL) slips premarket as free Wi‑Fi plan lands and earnings near

American Airlines stock (AAL) slips premarket as free Wi‑Fi plan lands and earnings near

American Airlines shares slipped 0.2% to $15.96 premarket Thursday after announcing free, AT&T-sponsored in-flight Wi‑Fi for AAdvantage loyalty members. The move follows similar offerings from Delta and United. Investors await late-January earnings for signs on demand and costs. UBS raised its price target on the stock to $21.
Nvidia stock rises in premarket as tough China payment terms put H200 demand back in focus

Nvidia stock rises in premarket as tough China payment terms put H200 demand back in focus

Nvidia is demanding full upfront payment and barring cancellations for H200 chip orders in China, as export approvals remain uncertain. NVDA shares rose 0.5% to $190.05 premarket. Chinese firms have ordered over 2 million H200 chips, but Nvidia holds only about 700,000 units in inventory. Beijing has asked some tech firms to pause orders while it considers requiring purchases of domestic AI chips.
8 January 2026
Immuneering (IMRX) stock jumps in premarket after 12-month pancreatic cancer survival update

Immuneering (IMRX) stock jumps in premarket after 12-month pancreatic cancer survival update

Immuneering shares surged 24% to $8.33 premarket after reporting 64% overall 12-month survival in a 34-patient Phase 2a pancreatic cancer trial. The company compared this to a 35% benchmark from standard chemotherapy. Median progression-free survival reached 8.5 months. Immuneering plans a larger data update and to start a Phase 3 trial in mid-2026.
Eli Lilly stock pops in premarket on $1.2 billion Ventyx deal — what traders watch next

Eli Lilly stock pops in premarket on $1.2 billion Ventyx deal — what traders watch next

Eli Lilly shares rose 4.1% premarket to $1,108.09 after the company agreed to buy Ventyx Biosciences for $1.2 billion in cash. The deal, expected to close in the first half of 2026, adds oral inflammation drugs to Lilly’s pipeline. Lilly will pay $14 per Ventyx share, a 62% premium to its recent average. Investors are watching for details on pipeline progress and spending ahead of Lilly’s next earnings call.
8 January 2026
Hyperscale Data (GPUS) stock jumps as company flags $369 mln in assets, touts Bitcoin war chest

Hyperscale Data (GPUS) stock jumps as company flags $369 mln in assets, touts Bitcoin war chest

Hyperscale Data Inc shares jumped about 38% in premarket trading Thursday after the company estimated year-end total assets at $369 million and net assets at $168 million. The company reported a bitcoin treasury of $80.2 million, roughly matching its market value. Figures are preliminary and unaudited. Hyperscale plans monthly asset updates and weekly bitcoin disclosures in 2026.
AST SpaceMobile stock tries to bounce after analyst calls valuation “irrational”

AST SpaceMobile stock tries to bounce after analyst calls valuation “irrational”

AST SpaceMobile shares rose 3.6% to $88.80 in premarket trading Thursday after falling 12% the previous session. Scotiabank downgraded the stock to Sector Underperform, citing high valuation and execution risks, and set a $45.60 price target. The stock traded between $83.91 and $95.34 Wednesday, closing at $85.73. Investors remain focused on the company’s rollout pace and competition from SpaceX’s Starlink.
8 January 2026
American Airlines stock (AAL) steadies in premarket after free Wi‑Fi rollout plan, analyst targets

American Airlines stock (AAL) steadies in premarket after free Wi‑Fi rollout plan, analyst targets

American Airlines shares slipped 0.1% to $15.97 premarket after announcing a phased rollout of free, AT&T-sponsored in-flight Wi‑Fi for AAdvantage members. TD Cowen raised its price target to $19 and BofA to $17, both citing demand momentum. The rollout will start with narrowbody and dual-class regional jets, reaching most flights by early spring.
8 January 2026
1 278 279 280 281 282 584

Stock Market Today

  • Medline (MDLN) Faces Valuation Headwinds After 10% Pullback Amid Premium P/E
    March 12, 2026, 2:24 AM EDT. Medline's (MDLN) shares fell roughly 10.5% over 30 days, trading around $42.39, despite a 4.4% year-to-date gain. The stock commands a price-to-earnings (P/E) ratio of 29.7x, above the US Medical Equipment industry's 27.2x and peer average of 26.5x, indicating a market premium. Analysts forecast earnings growth of 16.54% annually and revenue growth of 7.1%, with price targets about 25.5% higher than current levels. However, Medline's lower net profit margin of 4.1% (down from 4.7%), a modest 6% return on equity (ROE), and interest expenses not fully covered by earnings raise valuation concerns. The recent share pullback and fundamental challenges may temper investor expectations despite optimistic growth forecasts and earnings quality considerations.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 12.03.2026

12 March 2026
LIVEMarkets rolling coverageStarted: March 12, 2026, 12:00 AM EDTUpdated: March 12, 2026, 2:35 AM EDT Medline (MDLN) Faces Valuation Headwinds After 10% Pullback Amid Premium P/E March 12, 2026, 2:24 AM EDT. Medline's (MDLN) shares fell roughly **10.5% over 30 days**, trading around **$42.39**, despite a **4.4% year-to-date gain**. The stock commands a **price-to-earnings (P/E) ratio of 29.7x**, above the US Medical Equipment industry's 27.2x and peer average of 26.5x, indicating a market premium. Analysts forecast **earnings growth of 16.54% annually** and **revenue growth of 7.1%**, with price targets about **25.5% higher** than current levels. However, Medline's **lower net profit
XRP Price Today: Ripple’s Australia License Push Keeps XRP Near $1.40

XRP Price Today: Ripple’s Australia License Push Keeps XRP Near $1.40

11 March 2026
XRP traded near $1.40, down 1.4% Wednesday, after Ripple announced plans to acquire BC Payments Australia to secure an Australian Financial Services Licence. The move comes as Australia tightens licensing rules for digital-asset firms. Broader crypto markets remained cautious amid concerns over oil prices, Iran, and U.S. inflation. Ripple’s deal is pending completion.
Natural Gas Price Today: Europe Gas Holds Firm as Brussels Weighs Cap After Qatar Shock

Natural Gas Price Today: Europe Gas Holds Firm as Brussels Weighs Cap After Qatar Shock

11 March 2026
European natural gas prices held near 48 euros per megawatt hour Wednesday as Shell declared force majeure on Qatari LNG cargoes, with disruptions expected to hit from April. Asia is bidding up for replacement fuel, while Brussels considers subsidies or a price cap. LNG Canada increased shipments, but analysts warn Europe’s gas storage could end March far below average if Qatari supply issues persist.
Go toTop